근시 및 노안 치료 시장 : 질환별, 치료법별, 지역별

Myopia And Presbyopia Treatment Market is estimated to be valued at USD 31.05 Bn in 2026 and is expected to reach USD 54.97 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033.

Presbyopia and myopia are terms used to describe eye dysfunction. Myopia makes it difficult to see objects in the distance, and presbyopia makes it difficult for the natural lens to shift its focus between near and far objects. Presbyopia affects people between the ages of 40 and 50. Surgery and medication are both options for treating myopia and presbyopia. Additionally, contact lenses or glasses can be used to treat these conditions. Myopia and presbyopia are becoming more common worldwide. The most frequent cause of vision impairment in people under the age of 40 is myopia (nearsightedness), whereas presbyopia is the typical age-related loss of near focusing ability. Squinting, eye strain, and headaches are signs of myopia and presbyopia. The conditions can be corrected or treated with eyeglasses, contact lenses, or refractive surgeries. Moreover, eye drops containing medication are also emerging treatments for myopia and presbyopia. Increasing geriatric population is one of the major factors driving the growth of the market, as presbyopia is an age-related visual impairment. Myopia (nearsighted) is the most common cause of impaired vision in people under the age of 40 while presbyopia is the normal loss of near focusing ability that occurs with age.

Market Dynamics

Increasing launches of new products,treatments, mergers, and acquisitions by key market players are expected to drive the global myopia and presbyopia treatment market growth. For instance, on October 12, 2020, Eyenovia, Inc., a clinical stage ophthalmic biopharmaceutical company developing a pipeline of Microdose Array Print (MAPTM) therapeutics, and Bausch Health Companies Inc., its global eye health business, announced that an affiliate of Bausch Health Companies Inc. has acquired an exclusive license in the U.S. and Canada for the development and commercialization of an investigational microscopic print. This experimental atropine formulation is administered using Eyenovia, Inc. patented Optejet dispenser technology.

Key features of the study:

• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global myopia and presbyopia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include ALCON Inc., Bausch Health Companies Inc., EssilorLuxottica (Essilor Ltd.), Johnson & Johnson Vision, NIDEK CO. LTD., Topcon Corporation, Zeimer Ophthalmic Systems AG, and ZEISS International
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global myopia and presbyopia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global myopia and presbyopia treatment market

Detailed Segmentation:

• Global Myopia And Presbyopia Treatment Market, By Disease Type (Revenue, USD Bn, 2021 - 2033)
• Myopia
• Presbyopia
• Global Myopia And Presbyopia Treatment Market, By Treatment Type (Revenue, USD Bn, 2021 - 2033)
• Prescription Lenses
• Contact Lenses
• Surgery
• Medication
• Others
• Global Myopia And Presbyopia Treatment Market, By Region (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • North Africa
  • Central Africa
  • South Africa
• Company Profiles
• ALCON Inc.
• Bausch Health Companies Inc.
• EssilorLuxottica (Essilor Ltd.)
• Johnson & Johnson Vision
• NIDEK CO. LTD.
• Topcon Corporation
• Zeimer Ophthalmic Systems AG
• ZEISS International

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Disease Type
  • Market Snapshot, By Treatment Type
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Product Launches
• Epidemiology
• Merger, Acquisition, and Collaboration
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Myopia And Presbyopia Treatment Market, By Disease Type, 2021 - 2033, (US$ Billion)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Myopia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
• Presbyopia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

5. Global Myopia And Presbyopia Treatment Market, By Treatment Type, 2021-2033, (US$ Billion)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Prescription Lenses
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Contact Lenses
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Medication
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

6. Global Myopia And Presbyopia Treatment Market, By Region, 2021 - 2033, (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Region, 2022-2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021-2033, (US$ Billion)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

• ALCON Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bausch Health Companies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• EssilorLuxottica (Essilor Ltd.)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Johnson & Johnson Vision
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• NIDEK CO. LTD.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Topcon Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Zeimer Ophthalmic Systems AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ZEISS International
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

8. Section

• Research Methodology
• About Us